Needham Maintains Buy on Cardlytics, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Kyle Peterson has maintained a Buy rating on Cardlytics (NASDAQ:CDLX) and increased the price target from $12 to $15.
March 15, 2024 | 10:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Kyle Peterson reaffirmed a Buy rating on Cardlytics and raised the price target from $12 to $15.
The increase in price target by a reputable analyst like Kyle Peterson from Needham signals a strong vote of confidence in Cardlytics' future performance. This endorsement is likely to positively influence investor sentiment and could lead to a short-term increase in CDLX's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100